RT Journal Article
SR Electronic
T1 720 A phase 1/2 study of BDC-3042, a novel Dectin-2 agonistic antibody, in patients with advanced cancers
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A815
OP A815
DO 10.1136/jitc-2023-SITC2023.0720
VO 11
IS Suppl 1
A1 Giordano, Antonio
A1 Dumbrava, Ecaterina
A1 Parikh, Aparna R
A1 Kenkel, Justin
A1 Cai, Danlin
A1 Demady, Damon
A1 Xu, Lu
A1 Alonso, Michael N
A1 Ackerman, Shelley E
A1 Perez, Edith A
A1 Wilks, Sharon
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A815.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.